Joint Annual Meeting ISMRM-ESMRMB & ISMRT 31st Annual Meeting • 07-12 May 2022 • London, UK
08:00 | How to add values of PET in hybrid PET/MRI in cancer staging and prognostic prediction?
Tiffany Ting-Fang Shih
PET/MRI provides multi-parametric evaluation in cancer staging and serve as hybrid biomarkers. Hybrid imaging biomarkers may have association with pathological prognostic factors and survival. In endometrial cancer, SUVmax/ADCmin represented higher tumor metabolism and cellularity; and correlated with pathological prognostic factors. In pancreatic ductal adenocarcinoma, hybrid biomarker (MTV/ADCmin) showed negative correlation in progression-free survival. Patients with higher values of TLG or TLG/Peak ratio have shorter overall survival. In esophageal cancer, MTV/ADCmin may predict overall survival. In further, PET can make MR reading easier for lymphadenopathy and systemic staging. PET/MR can pave to precision medicine and better convenience for the aging society. |
||
08:30 | MR Linac
Marielle Philippens
The integration of an MRI system and a linear accelator is challenging due to magnetic and radiofrequncy interference of both systems and the attenuation of the photon beam with the magnet. Magnetic fields up to 1.5T have been used. These systems offer online adaptation of the target, gating and real-time tracking.
|
The International Society for Magnetic Resonance in Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.